Diabetes
News
FDA approves cognitive-behavioral app for adults with type 2 diabetes
The app will be available to patients exclusively by prescription, with a planned 90-day use duration.
Conference Coverage
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
“The EDIC study is now shifting its focus during the next 5 years to understand the clinical course of type 1 diabetes in the setting of advancing...
Latest News
Weighing childhood obesity interventions
The long-term effects of these new agents on children and teens are poorly understood, and both medication and surgery are associated with...
Latest News
Treating obesity: Will new drugs end the crisis?
The drugs offer new hope to millions with obesity complications. But to truly turn the tide on our 42% obesity rate, much more work remains to be...
Latest News
GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosis
“GLP-1 RAs may be a treatment option for diabetes patients with liver cirrhosis,” but additional studies are needed to confirm the results, the...
Conference Coverage
Education before Ramadan key to safe fasting with diabetes
“With correct advice and support” from knowledgeable health care professionals “most people with type 2 diabetes can fast safely during Ramadan...
Conference Coverage
COORDINATE-Diabetes: A ‘wake-up call’ for many specialties
“I look at COORDINATE as a wake-up call to the need for multispecialty approaches to people with type 2 diabetes and cardiovascular disease.”
Conference Coverage
‘Artificial pancreas’ for all type 1 diabetes pregnancies?
The hybrid closed-loop system is not available in the United States but other systems are available and sometimes used off label in pregnancy.
Conference Coverage
Thirty-three percent of type 1 diabetes patients insulin free with stem cells
Engraftment of Vertex Pharmaceutical’s VX-880 stem cell–derived islets has now been achieved in six patients, two of whom are insulin-independent...
Latest News
WHO plans to declare common sweetener as possible carcinogen
Aspartame would join the “possibly” carcinogenic group, which includes gasoline engine exhaust and working as a dry cleaner.
Commentary
Tirzepatide: Therapeutic titan or costly cure?
Positioning tirzepatide as the first injectable of choice after oral treatment escalation with metformin and an SGLT2 inhibitor may remain an...